Skip to main content
Caplight Logo









CreatSens Health

CreatSens Health

Private
ReusHealthcare & Life Scienceshttps://renalyse.com/

Last Round

Seed

Oct 9, 2023

Total Funding Raised

$1.19M

Company Overview

CreatSens Health is a healthtech company that develops a point-of-care device for creatinine and potassium determination in blood and a technological platform for renal monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Telemedicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticschronic kidney diseaseCKDPOC diagnosticsat-home testingmedical deviceremote patient monitoringRPMkidney function testbiomarker analysistelehealthcreatinine monitoringpotassium monitoringdiagnostic consumablesMedTechdigital healthHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CreatSens Health Comparables

Compare CreatSens Health with similar companies based on industry and business-model similarity.

CreatSens Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioRenal
85%
Kalium Health
85%
Jana Care
83%

CreatSens Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 9, 2023
AcceleratorMay 14, 2019

Key People

Founding team and executive leadership

Marta Novell Recasens

Co-Founder & CTO

Founding Team

Tomàs Guinovart

Co-Founder & COO

Founding Team

CreatSens Health Investors

Notable investors and investment history

CreatSens Health investors
InvestorRounds
Eurostars SME programmeSeed
GENESIS VenturesSeed, Accelerator
BStartup Banco SabadellAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Grew 30% QoQ from 10 to 13 employees.

  • Oct 9, 2023

    $1.05M raised from fundacionbotin-org and GENESIS Ventures.

CreatSens Health Filings

Explore SEC and related filing metadata, where available.

CreatSens Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CreatSens Health's valuation, stock price, and market status.

Is CreatSens Health a public or private company?

CreatSens Health is a private company.

What is the current stock price of CreatSens Health?

CreatSens Health is a private company, so its shares have no public market price. Caplight tracks CreatSens Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CreatSens Health worth (valuation)?

Valuation information for CreatSens Health is not publicly available.

Can I buy CreatSens Health stock?

CreatSens Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CreatSens Health's last funding round?

CreatSens Health's most recent funding round was Seed on October 9, 2023.

Who are the main investors in CreatSens Health?

Key investors in CreatSens Health include GENESIS Ventures, BStartup Banco Sabadell.

Will CreatSens Health IPO soon?

No public IPO plans have been announced for CreatSens Health.

How can I track CreatSens Health secondary market activity?

Caplight tracks bids, offers, and trades in CreatSens Health's shares on secondary markets.

Firmographic Details

HeadquartersReus
Employee Range8
Year Founded2017
Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?